SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-030413
Filing Date
2020-11-04
Accepted
2020-11-04 20:00:14
Documents
1
Period of Report
2020-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11209
  Complete submission text file 0000899243-20-030413.txt   12711
Mailing Address C/O EPIRUS BIOPHARMACEUTICALS, INC. 699 BOYLSTON STREET, 8TH FLOOR BOSTON MA 02116
Business Address
Munshi Amit (Reporting) CIK: 0001612551 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39655 | Film No.: 201288226

Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto, Inc. (Issuer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations